HuGE Literature Finder
Records
1
-
3
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement disorders : official journal of the Movement Disorder Society 2019 Jul . Agalliu Ilir, Ortega Roberto A, Luciano Marta San, Mirelman Anat, Pont-Sunyer Claustre, Brockmann Kathrin, Vilas Dolores, Tolosa Eduardo, Berg Daniela, Warø Bjørg, Glickman Amanda, Raymond Deborah, Inzelberg Rivka, Ruiz-Martinez Javier, Mondragon Elisabet, Friedman Eitan, Hassin-Baer Sharon, Alcalay Roy N, Mejia-Santana Helen, Aasly Jan, Foroud Tatiana, Marder Karen, Giladi Nir, Bressman Susan, Saunders-Pullman Rach |
Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease. Brain and behavior 2018 Jan 8 (1): e00858. Warø Bjørg Johanne, Aasly Jan |
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 2012 Feb . Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: